However, the analgesic effect of EA on the osteoarthritis rat model was blocked by systemic ketanserin (Figure 2), indicating that EA treatment induced the release of serotonin, which activated 5-HT2A/2C receptors to alleviate pain. This evidence concerns the gene HTR2A and osteoarthritis.